AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of China Pharmaceutical University Article
PDF (585.3 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Invited Article | Publishing Language: Chinese | Open Access

Recent progress in China’s radiopharmaceuticals

State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050, China
Show Author Information

Abstract

Radiopharmaceuticals play an indispensable role in the precise diagnosis and treatment of major diseases. Based on the latest regulations and policies related to radiopharmaceuticals issued in China in 2024, relevant literature published by Chinese researchers in domestic and international journals, and the latest clinical research developments in China, this review systematically summarizes the major advances in radiopharmaceutical research in China. It covers the analysis of relevant policies and regulations, breakthroughs in basic research, developments in clinical research, and the latest R&D advances made by Chinese radiopharmaceutical companies. Finally, the future prospects of China’s radiopharmaceutical field are discussed.

Keywords

radiopharmaceuticalsmedical isotopesmolecular imagingtumor targetsclinical trials
CLC number: R981 Document code: A Article ID: 1000-5048(2026)-4-534-6

References

【1】
【1】
 
 
Crossref Google Scholar
Journal of China Pharmaceutical University
Volume 57 Issue 4,
August 2026
Pages 534-539
DOI: 10.11665/j.issn.1000-5048.2026060101

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
HU K, GAO X, WANG R. Recent progress in China’s radiopharmaceuticals. Journal of China Pharmaceutical University, 2026, 57(4): 534-539. https://doi.org/10.11665/j.issn.1000-5048.2026060101

7

Views

0

Downloads

0

Crossref

0

CSCD
Received: 01 June 2026
Published: 25 August 2026
© 2026 The Editorial Office of Journal of China Pharmaceutical University

This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/by-nc-nd/4.0/).